Muscle pathology without severe nerve pathology in a new mouse model of charcot-marie-tooth disease type 2E

Human Molecular Genetics

Volumn 20, Issue 13, 2011, Pages 2535-2548

  Shen, Hailian ^a,c   Barry, Devin M ^a   Dale, Jeffrey M ^a   Garcia, Virginia B ^a   Calcutt, Nigel A ^b   Garcia, Michael L ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; LYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY POSTURE; DENERVATION; DISEASE SEVERITY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HINDLIMB; LOCOMOTION; MOTOR NERVE CONDUCTION; MOUSE; MUSCLE ATROPHY; MUSCLE DISEASE; NEUROFILAMENT; NEUROPATHY; NONHUMAN; PATHOGENESIS; PERIKARYON; PHENOTYPE; PRIORITY JOURNAL; SYMPTOM;

ANIMALS; AXONS; CHARCOT-MARIE-TOOTH DISEASE; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUSCLE DENERVATION; MUSCLES; MUSCULAR ATROPHY; MUTATION; NERVE TISSUE; NEURAL CONDUCTION; NEUROFILAMENT PROTEINS; PHENOTYPE; PHOSPHORYLATION;

MUS;

EID: 79958729463     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr152     Document Type: Article

References (35)

1. Skre, H. (1974) Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet., 6, 98-118.
2. Emery, A.E. (1991) Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul. Disord., 1, 19-29.
3. Mersiyanova, I.V., Perepelov, A.V., Polyakov, A.V., Sitnikov, V.F., Dadali, E.L., Oparin, R.B., Petrin, A.N. and Evgrafov, O.V. (2000) A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet., 67, 37-46.
4. De Jonghe, P., Mersivanova, I., Nelis, E., Del Favero, J., Martin, J.J., Van Broeckhoven, C., Evgrafov, O. and Timmerman, V. (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann. Neurol., 49, 245-249.
5. Georgiou, D.M., Zidar, J., Korosec, M., Middleton, L.T., Kyriakides, T. and Christodoulou, K. (2002) A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics, 4,93-96.
6. Yoshihara, T., Yamamoto, M., Hattori, N., Misu, K., Mori, K., Koike, H. and Sobue, G. (2002) Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot-Marie-Tooth disease patients and normal individuals. J. Peripher. Nerv. Syst., 7, 221-224.
7. Jordanova, A., De Jonghe, P., Boerkoel, C.F., Takashima, H., De Vriendt, E., Ceuterick, C., Martin, J.J., Butler, I.J., Mancias, P., Papasozomenos, S. et al. (2003) Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain, 126, 590-597.
8. Zuchner, S., Vorgerd, M., Sindern, E. and Schroder, J.M. (2004) The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy. Neuromuscul. Disord., 14, 147-157.
9. Abe, A., Numakura, C., Saito, K., Koide, H., Oka, N., Honma, A., Kishikawa, Y. and Hayasaka, K. (2009) Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype. J. Hum. Genet., 54,94-97.
10. Yum, S.W., Zhang, J., Mo, K., Li, J. and Scherer, S.S. (2009) A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy. Ann. Neurol., 66, 759-770.
11. Miltenberger-Miltenyi, G., Janecke, A.R., Wanschitz, J.V., Timmerman, V., Windpassinger, C., Auer-Grumbach, M. and Loscher, W.N. (2007) Clinical and electrophysiological features in Charcot-Marie-Toothdisease with mutations in the NEFL gene. Arch. Neurol., 64, 966-970.
12. Ching, G.Y. and Liem, R.K. (1993) Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol., 122, 1323-1335.
13. Lee, M.K., Xu, Z., Wong, P.C. and Cleveland, D.W. (1993) Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol., 122, 1337-1350.
14. Yuan, A., Rao, M.V., Sasaki, T., Chen, Y., Kumar, A., Veeranna, Liem, R.K.H., Eyer, J., Peterson, A.C., Julien, J.-P. et al. (2006) {alpha}-Internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS. J. Neurosci., 26, 10006-10019.
15. Ohara, O., Gahara, Y., Miyake, T., Teraoka, H. and Kitamura, T. (1993) Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene. J. Cell Biol., 121, 387-395.
16. Zhu, Q., Couillard-Després, S. and Julien, J.P. (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol., 148, 299-316.
17. Sakaguchi, T., Okada, M., Kitamura, T. and Kawasaki, K. (1993) Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail. Neurosci. Lett., 153, 65-68.
18. Kriz, J., Zhu, Q., Julien, J.P. and Padjen, A.L. (2000) Electrophysiological properties of axons in mice lacking neurofilament subunit genes: disparity between conduction velocity and axon diameter in absence of NF-H. Brain Res., 885, 32-44.
19. Brownlees, J., Ackerley, S., Grierson, A.J., Jacobsen, N.J., Shea, K., Anderton, B.H., Leigh, P.N., Shaw, C.E. and Miller, C.C. (2002) Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet., 11, 2837-2844.
20. Perez-Olle, R., Leung, C.L. and Liem, R.K. (2002) Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J. Cell Sci., 115, 4937-4946.
21. Perez-Olle, R., Jones, S.T. and Liem, R.K. (2004) Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models. Hum. Mol. Genet., 13, 2207-2220.
22. Dequen, F., Filali, M., Lariviere, R.C., Perrot, R., Hisanaga, S. and Julien, J.P. (2010) Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E. Hum. Mol. Genet., 19, 2616-2629.
23. Bagby, G.J., Johnson, J.L., Bennett, B.W. and Shepherd, R.E. (1986) Muscle lipoprotein lipase activity in voluntarily exercising rats. J. Appl. Physiol., 60, 1623-1627.
24. Hirano, A., Donnenfeld, H., Sasaki, S. and Nakano, I. (1984) Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol., 43, 461-470.
25. Hirano, A., Nakano, I., Kurland, L.T., Mulder, D.W., Holley, P.W. and Saccomanno, G. (1984) Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol., 43, 471-480.
26. Garcia, M.L., Singleton, A.B., Hernandez, D., Ward, C.M., Evey, C., Sapp, P.A., Hardy, J., Brown, R.H. Jr and Cleveland, D.W. (2006) Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis. Neurobiol. Dis., 21, 102-109.
27. Garcia, M.L., Lobsiger, C.S., Shah, S.B., Deerinck, T.J., Crum, J., Young, D., Ward, C.M., Crawford, T.O., Gotow, T., Uchiyama, Y. et al. (2003) NF-M is an essential target for the myelin-directed 'outside-in' signaling cascade that mediates radial axonal growth. J. Cell Biol., 163, 1011-1020.
28. Garcia, M.L., Rao, M.V., Fujimoto, J., Garcia, V.B., Shah, S.B., Crum, J., Gotow, T., Uchiyama, Y., Ellisman, M., Calcutt, N.A. et al. (2009) Phosphorylation of highly conserved neurofilament medium KSP repeats is not required for myelin-dependent radial axonal growth. J. Neurosci., 29, 1277-1284.
29. Waxman, S.G. (1980) Determinants of conduction velocity in myelinated nerve fibers. Muscle Nerve, 3, 141-150.
30. Kong, L., Wang, X., Choe, D.W., Polley, M., Burnett, B.G., Bosch-Marce, M., Griffin, J.W., Rich, M.M. and Sumner, C.J. (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci., 29, 842-851.
31. Kariya, S., Park, G.-H., Maeno-Hikichi, Y., Leykekhman, O., Lutz, C., Arkovitz, M.S., Landmesser, L.T. and Monani, U.R. (2008) Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet., 17, 2552-2569.
32. Murray, L.M., Comley, L.H., Thomson, D., Parkinson, N., Talbot, K. and Gillingwater, T.H. (2008) Selective vulnerability of motor neurons and dissociation of preand post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet., 17, 949-962.
33. Chen, X.J., Levedakou, E.N., Millen, K.J., Wollmann, R.L., Soliven, B. and Popko, B. (2007) Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic dynein heavy chain 1 gene. J. Neurosci., 27, 14515-14524.
34. Dupuis, L., Fergani, A., Braunstein, K.E., Eschbach, J., Holl, N., Rene, F., Gonzalez De Aguilar, J.L., Zoerner, B., Schwalenstocker, B., Ludolph, A.C. et al. (2009) Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease. Exp. Neurol., 215, 146-152.
35. Calcutt, N.A., Tomlinson, D.R. and Biswas, S. (1990) Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy. Diabetes, 39, 663-666.